ClinConnect ClinConnect Logo
Search / Trial NCT06788860

Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger

Launched by MOHAMED MAHER ISMAIL AHMED ELASHMAWY · Jan 17, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Trigger Finger A1 Pulley Release Ultrasound Guided Technique

ClinConnect Summary

This clinical trial is studying a new treatment for a condition called trigger finger, which occurs when a finger gets stuck in a bent position due to a problem with the tendons. The researchers are looking at a procedure called ultrasound-guided needle knife release, which is a minimally invasive method to help relieve symptoms. They want to see how safe and effective this treatment is compared to traditional methods and how quickly patients recover after the procedure.

To participate in the trial, you should be between 65 and 74 years old and have been experiencing moderate to severe symptoms of trigger finger for at least three months, despite trying other treatments. Unfortunately, if you have other medical conditions like diabetes or rheumatoid arthritis, or if you've had surgery on the affected finger before, you won't be eligible. If you join the trial, you can expect to receive the new treatment and be monitored closely to assess how well it works for your condition. This trial is currently recruiting participants, and your involvement could help improve treatment options for others with trigger finger in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Idiopathic TF at the level of A1 pulley
  • Trigger finger of Green's grades II or III or IV (moderate to severe)
  • Symptoms persist for at least three months despite conservative treatments.
  • Ability to provide informed consent and comply with follow-up requirements.
  • Exclusion Criteria:
  • Patients with secondary causes of TF like diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, and sarcoidosis.
  • Patients with TF of Green's grade I.
  • Previous surgical intervention on the affected digit.
  • Allergy or contraindication to local anesthetics.
  • Pregnancy or lactation.
  • Inability to comply with follow-up assessments.

About Mohamed Maher Ismail Ahmed Elashmawy

Mohamed Maher Ismail Ahmed Elashmawy is a dedicated clinical trial sponsor with extensive experience in overseeing and managing clinical research initiatives. Committed to advancing medical knowledge and improving patient outcomes, he actively collaborates with healthcare professionals and research institutions to ensure the integrity and efficacy of clinical trials. His expertise encompasses various therapeutic areas, and he is focused on adhering to regulatory standards while fostering innovation in the development of new treatments. Elashmawy's leadership is characterized by a strong emphasis on ethical practices, rigorous data analysis, and a commitment to enhancing the quality of clinical research.

Locations

Mansoura, Dakahlia, Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported